Gryphon Financial Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-4,765
| Closed | -$258K | – | 269 |
|
2024
Q1 | $258K | Sell |
4,765
-470
| -9% | -$25.5K | 0.04% | 223 |
|
2023
Q4 | $280K | Buy |
5,235
+995
| +23% | +$53.2K | 0.05% | 195 |
|
2023
Q3 | $246K | Buy |
4,240
+664
| +19% | +$38.5K | 0.06% | 159 |
|
2023
Q2 | $229K | Sell |
3,576
-1,768
| -33% | -$113K | 0.05% | 175 |
|
2023
Q1 | $370K | Sell |
5,344
-529
| -9% | -$36.7K | 0.08% | 130 |
|
2022
Q4 | $423K | Sell |
5,873
-521
| -8% | -$37.5K | 0.1% | 111 |
|
2022
Q3 | $454K | Buy |
6,394
+595
| +10% | +$42.2K | 0.11% | 100 |
|
2022
Q2 | $447K | Buy |
5,799
+1,599
| +38% | +$123K | 0.11% | 106 |
|
2022
Q1 | $307K | Buy |
4,200
+71
| +2% | +$5.19K | 0.06% | 154 |
|
2021
Q4 | $257K | Sell |
4,129
-313
| -7% | -$19.5K | 0.05% | 174 |
|
2021
Q3 | $262K | Sell |
4,442
-552
| -11% | -$32.6K | 0.06% | 166 |
|
2021
Q2 | $321K | Buy |
4,994
+903
| +22% | +$58K | 0.07% | 134 |
|
2021
Q1 | $257K | Buy |
4,091
+30
| +0.7% | +$1.89K | 0.06% | 145 |
|
2020
Q4 | $252K | Sell |
4,061
-604
| -13% | -$37.5K | 0.06% | 134 |
|
2020
Q3 | $282K | Buy |
+4,665
| New | +$282K | 0.08% | 122 |
|
2020
Q2 | – | Sell |
-4,626
| Closed | -$257K | – | 137 |
|
2020
Q1 | $257K | Sell |
4,626
-1,794
| -28% | -$99.7K | 0.09% | 118 |
|
2019
Q4 | $412K | Buy |
+6,420
| New | +$412K | 0.11% | 108 |
|
2018
Q4 | – | Sell |
-5,892
| Closed | -$366K | – | 196 |
|
2018
Q3 | $366K | Buy |
5,892
+3,258
| +124% | +$202K | 0.11% | 97 |
|
2018
Q2 | $146K | Sell |
2,634
-160
| -6% | -$8.87K | 0.07% | 102 |
|
2018
Q1 | $177K | Sell |
2,794
-34
| -1% | -$2.15K | 0.09% | 86 |
|
2017
Q4 | $173K | Buy |
+2,828
| New | +$173K | 0.1% | 91 |
|